Mycobacterium abscessus is a type of nontuberculous mycobacterium that poses a significant health risk, particularly for individuals with cystic fibrosis (CF). This opportunistic pathogen can ...

i>Mycobacterium abscessus</i> has recently emerged as a significant global threat to individuals with cystic fibrosis (CF) and other lung diseases. It was previously thought that patients acquired ...

11, 2024 — A Cystic Fibrosis drug targeting the basic defect ... water supplies may increase the risk of nontuberculous mycobacteria (NTM) pulmonary ... Triple Combination Therapy Brings Lasting ...

Chronic bacterial infection is one of the key challenges in caring for patients with cystic fibrosis (CF). Effective infection control requires appropriate administration of antibiotics.

BV500 reaches second milestone, with the advancement of multiple broadly profiled and highly potent oral Lead candidates with demonstrated broad-spectrum in vitro and in vivo efficacy against ...

Purpose. The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF) lung disease is described. Dyspnea, the sensation of breathlessness or labored ...